Search

everythinglearnresearchcommunity

for

Search:↓

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

New compounds show promise as nonsteroidal treatments for hair loss.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Dutasteride may reduce insulin sensitivity and increase body fat.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Clascoterone may be an effective topical treatment for hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.